Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30
Reach urologists

IC/PBS/BPS/HBS
UroToday's IC/PBS/BPS section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of interstitial cystitis/painful bladder syndrome/bladder pain syndrome. Also available are conference coverage for all timely IC/PBS/BPS, audio podcasts and downloadable slides from UroToday's slide library.
Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Search    Display results per page
Results 361 - 375 of 446
<< Start < Prev 21 22 23 24 25 26 27 28 29 30 Next > End >>
Efficacy of Tricyclic Antidepressant is Associated with Beta2-Adrenoceptor Genotype in Patients with Interstitial Cystitis
Wednesday, 27 December 2006
BERKELEY, CA (UroToday.com) - Tricyclic antidepressant therapy (amitriptyline in particular) is effective in treating the symptoms of PBS/IC. These drugs block the active transport system that is involved in the re-uptake of serotonin and noradrenaline.
read more

Prevalence and Correlates for Interstitial Cystitis Symptoms in Women Participating in a Health Screening Project
Friday, 24 November 2006
BERKELEY, CA (UroToday.com) - Nine hundred and eighty-one women attending a voluntary health survey project in Vienna underwent a detailed health investigation and completed a questionnaire containing the O'Leary-Sant symptom and problem indexes. Women with symptom scores and problem scores of over 12 were considered most likely to have interstitial cystitis.
read more

The Molecular Basis of Urgency: Regional Difference of Vanilloid Receptor Expression in the Human Urinary Bladder
Wednesday, 22 November 2006
BERKELEY, CA (UroToday.com) - Transient receptor potential vanilloid-1 receptor (TRPV1) is activated by capsaicin, the drug injected subcutaneously by scientists in an attempt to study C fiber sensitization.
read more

Report on the NIDDK International Frontiers In PBS/IC Symposium
Monday, 20 November 2006
BETHESDA, MD (UroToday.com) - October 26 - 27, 2006 - The recently concluded NIDDK meeting on Frontiers in Painful Bladder Syndrome / Interstitial Cystitis was extremely successful and well-received. It was chaired by Deborah Erickson, Professor of Urology at the University of Kentucky.
read more

Safety and Efficacy of Hyperbaric Oxygen Therapy for the Treatment of Interstitial Cystitis: A Randomized, Sham Controlled, Double-Blind Trial.
Wednesday, 11 October 2006
BERKELEY, CA (UroToday.com) - Hyperbaric Oxygen (HBO) therapy aims at ischemia by leading to a net gain in oxygen concentration in tissues.
read more

Uronate Peaks and Urinary Hyaluronic Acid Levels Correlate With Interstitial Cystitis Severity
Tuesday, 10 October 2006
BERKELEY, CA (UroToday.com) - Several promising markers, led by antiproliferative factor and heparin binding epidermal growth factor-like growth factor may eventually be useful in diagnosing interstitial cystitis.
read more

EGF and HB-EGF Modulate Inward Potassium Current in Human Bladder Urothelial Cells from Normal and Interstitial Cystitis Patients
Monday, 09 October 2006
BERKELEY, CA (UroToday.com) - There are currently two well-known bladder hypersensory syndromes - overactive bladder (OAB) and interstitial cystitis (BPS/IC). Because BPS/IC is associated with chronic bladder pain, it represents potentially a more challenging clinical problem. There are no treatments that target specifically the bladder sensory pathways.
read more

Techniques for the Intradetrusor Administration of Botulinum Toxin
Wednesday, 04 October 2006
BERKELEY, CA (UroToday.com) - The rationale for using botulinum toxin (BTX) injections into the bladder in preliminary studies was based on its known effect of blocking the parasympathetic release of acetylcholine, akin to its mechanism of action in skeletal muscle.
read more

Efficiency of Questionnaires Used to Screen for Interstitial Cystitis
Wednesday, 27 September 2006
BERKELEY, CA (UroToday.com) - Studies have used the OSPI and PUF questionnaires to screen individuals who present with symptoms of BPS/IC and, thereby, determine the prevalence of BPS/IC in a general population.
read more

Ketamine for Treatment of Catheter Related Bladder Discomfort: A Prospective, Randomized, Placebo Controlled and Double Blind Study
Tuesday, 26 September 2006
BERKELEY, CA (UroToday.com) - Catheter related bladder discomfort is common in patients awakening from anesthesia who have had urinary catheterization during surgery.
read more

Transient Receptor Potential Vanilloid Receptor Subtype 1 in Painful Bladder Syndrome and its Correlation with Pain
Monday, 25 September 2006
BERKELEY, CA (UroToday.com) - The involvement of C-fiber afferents in urinary frequency and pain associated with BPS/IC and neurogenic detrusor overactivity has been established, but relatively little is known of the ion channels and receptors expressed by these fibers in human urinary disorders.
read more

Oral Treatment with a Vitamin D3 Analogue (BXL628) has Anti-Inflammatory Effects in Rodent Model of Interstitial Cystitis
Friday, 22 September 2006
BERKELEY, CA (UroToday.com) - The active form of vitamin D, calcitriol or 1,25(OH)2D3, is a secosteroid hormone that has been extensively studied over several years.
read more

What is the Fate of the Leftover Bladder after Supravesical Diversion for Benign Disease?
Tuesday, 22 August 2006
BERKELEY, CA (UroToday.com) - Ureteroileal cutaneous diversion was propagated by Bricker in 1950 for diversion after cystectomy for bladder cancer.
read more

Bladder Urothelium in PBS/IC Shows Distinct Differences in Keratin Profiles
Friday, 18 August 2006
BERKELEY, CA (UroToday.com) - Research groups from the Netherlands and Denmark led by Pilar Laguna studied urothelial involvement in PBS/IC by characterizing the keratin phenotype of bladder urothelium in 18 patients with the disorder.
read more

Poor Response to Antihistamine Therapy in PBS/IC May Relate to Ineffectiveness of Chosen Antihistamine or Weakening of Sphincteric Function
Friday, 11 August 2006
BERKELEY, CA (UroToday.com) - The potent inflammatory mediator histamine and other bioamines (e.g., serotonin) are possibly involved in the pathophysiology of PBS/IC.
read more

Focus on IC/PBS/BPS/HBS



Focus on IC/PBS/BPS/HBS condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.



International Painful Bladder Foundation Newsletter

- Issue 18, October 2009

International Painful Bladder Foundation Newsletter

- Issue 17, July 2009

Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)

- An Exclusive Report from the 2008 Asian IC Guideline Meeting



Chronic pelvic pain syndromes: Clinical, urodynamic, and urothelial observations

- by Charles W. Butrick, MD

Results of Endovesical Hyaluronic Acid/Chondroitin Sulfate in the Treatment of Interstitial Cystitis/Painful Bladder Syndrome

- by Daniele Porru, MD, et al.

Treatment of Bladder Pain Syndrome/Interstitial Cystitis 2008: Can We Make Evidence-Based Decisions?

- by Magnus Fall, MD, PhD



Bladder pain syndrome/interstitial cystitis in a Danish population: a study using the 2008 criteria of the European Society for the Study of Interstitial Cystitis

Validation of a modified National Institutes of Health Chronic Prostatitis Symptom Index to assess genitourinary pain in both men and women

Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis

Differentiating interstitial cystitis from similar conditions commonly seen in gynecologic practice

Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes

Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome

Increased Vascular Endothelial Growth Factor Expression in Patients with Bladder Pain Syndrome/Interstitial Cystitis: Its Association with Pain Severity and Glomerulations

Increased Startle Responses in Interstitial Cystitis: Evidence for Central Hyperresponsiveness to Visceral Related Threat

Goal Achievement Provides New Insights Into Interstitial Cystitis/Painful Bladder Syndrome Symptoms and Outcomes

The Significance of Potassium Chloride Sensitivity Test and Urinary Uronic Acid Level in the Diagnosis of Chronic Pelvic Pain Syndrome

Urothelial Expression of Neuropilins and VEGF Receptors in Control and Interstitial Cystitis Patients

Effect of Intravesical Glycosaminoglycan Substitution Therapy on Bladder Pain Syndrome/Interstitial Cystitis, Bladder Capacity and Potassium Sensitivity

A Real-Life Multicentre Clinical Practice Study to Evaluate the Efficacy and Safety of Intravesical Chondroitin Sulphate for the Treatment of Interstitial Cystitis

Depression, Abuse and its Relationship to Interstitial Cystitis

Treatment of Bladder Pain Syndrome/Interstitial Cystitis 2008: Can We Make Evidence-Based Decisions?

- all editorials by Philip M. Hanno, MD, MPH



A Practical Approach to Diagnosis and Treatment of Interstitial Cystitis

- by Robert Evans, MD, et al.

Urodynamic Evaluation of Patients With Chronic Pelvic Pain Syndrome

- by Hashem Hafez, MD

A Randomized Controlled Trial of Bacillus Calmette-Guerin and Botulinum Toxin-A for the Treatment of Refractory Interstitial Cystitis

- by Yasser A. Farahat, MD, et al.



ImageChronic Pelvic Pain in Women: Still a Challenge







Investigation of the function of integrin-mediated bacterial adherence proteins and their receptors in women with recurrent bacterial cystitits and interstitial cystitis

- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner's ulcer subtype interstitial cystitis

- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

Axonopathic changes of visceral nerve endings in urinary bladder in interstitial cystitis: An ultrastructural study

- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

Infection/Inflammation of Genitourinary Tract: Interstitial Cystitis

- Session Higlight by Philip M. Hanno, MD, MPH from the 2009 Annual Meeting of the American Urological Association (AUA)

Interstitial Cystitis and Pelvic Pain Syndromes

- Presented by Grannum R. Sant, MD, FRCS, FACS at the 2008 Masters in Urology Conference

Interstitial Cystitis and Pelvic Pain Syndromes

- Written and Presented by Grannum R. Sant, MD, FRCS, FACS at the 2008 Masters in Urology Conference

Defining the Urologic Chronic Pelvic Pain Syndromes: A New Beginning

- Session Highlights by Philip M. Hanno, MD, MPH from the 2008 National Institute of Diabetes and Kidney Diseases Conference

Bladder Pain Syndrome: Committee Meeting

- Session Highlight by William Jaffe, MD from the 4th International Consultation on Incontinence

Bladder Pain Syndrome: Committee Meeting

- Presented by Philip N. Hanno, MD, MPH, et al. at the 4th International Consultation on Incontinence

European Society for the Study of Interstitial Cystitis (ESSIC) Annual Meeting

- Session Highlights by Philip M. Hanno, MD, MPH from the 2008 European Society for the Study of Interstitial Cystitis (ESSIC) Annual Meeting

Society for Urodynamics and Female Urology (SUFU)

- IC/PBS/BPS/HBS Abstracts from the SUFU 2008 Meeting

 
<< Start < Prev 21 22 23 24 25 26 27 28 29 30 Next > End >>
Results 361 - 375 of 446
back

UroToday, 1802 Fifth Street, Berkeley CA 94710
510.540.0930 (fax), info@urotoday.com
ISSN 1939-4810
About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use


Privacy Policy | © 2009 UroToday ® All Rights Reserved

Member's Section

Login

Sign Up

Quick Search


Advanced Search

Featured Conference

Media and Publisher

Advertising Rates
Reprints

Working with Industry

Case Studies
Sponsorship Opportunities

Interstitial Cystitis
Sponsored By